Tirzepatide-induced ketoacidosis in non-diabetic patients Article Swipe
Pathan Mohamad Rafe Iqbal
,
Ossama Maadarani
,
Zouheir Bitar
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.12890/2024_004357
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.12890/2024_004357
Background: Tirzepatide is a novel glucagon-like peptide 1/glucose-dependent insulinotropic peptide (GLP-1/GIP) receptor agonist. It was recently approved for diabetes control and weight reduction in non-diabetic patients. Case description: We report the first case of ketoacidosis after the use of tirzepatide in an obese non-diabetic patient, secondary to the possibility of starvation ketoacidosis and insulin resistance. Conclusion: The dual-acting GLP-1 and GIP receptor agonists, tirzepatide, can induce ketoacidosis in obese non-diabetic patients.
Related Topics
Concepts
Medicine
Diabetic ketoacidosis
Ketoacidosis
Internal medicine
Endocrinology
Starvation
Agonist
Insulin resistance
Diabetes mellitus
Glucagon-like peptide-1
Insulin
Weight loss
Obesity
Receptor
Type 2 diabetes
Type 1 diabetes
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.12890/2024_004357
- https://www.ejcrim.com/index.php/EJCRIM/article/download/4357/3891
- OA Status
- gold
- Cited By
- 9
- References
- 17
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4392641675
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4392641675Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.12890/2024_004357Digital Object Identifier
- Title
-
Tirzepatide-induced ketoacidosis in non-diabetic patientsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-03-11Full publication date if available
- Authors
-
Pathan Mohamad Rafe Iqbal, Ossama Maadarani, Zouheir BitarList of authors in order
- Landing page
-
https://doi.org/10.12890/2024_004357Publisher landing page
- PDF URL
-
https://www.ejcrim.com/index.php/EJCRIM/article/download/4357/3891Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.ejcrim.com/index.php/EJCRIM/article/download/4357/3891Direct OA link when available
- Concepts
-
Medicine, Diabetic ketoacidosis, Ketoacidosis, Internal medicine, Endocrinology, Starvation, Agonist, Insulin resistance, Diabetes mellitus, Glucagon-like peptide-1, Insulin, Weight loss, Obesity, Receptor, Type 2 diabetes, Type 1 diabetesTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
9Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 6, 2024: 3Per-year citation counts (last 5 years)
- References (count)
-
17Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4392641675 |
|---|---|
| doi | https://doi.org/10.12890/2024_004357 |
| ids.doi | https://doi.org/10.12890/2024_004357 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38584893 |
| ids.openalex | https://openalex.org/W4392641675 |
| fwci | 6.80683771 |
| type | article |
| title | Tirzepatide-induced ketoacidosis in non-diabetic patients |
| biblio.issue | 4 |
| biblio.volume | 11 |
| biblio.last_page | 004357 |
| biblio.first_page | 004357 |
| topics[0].id | https://openalex.org/T12267 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2737 |
| topics[0].subfield.display_name | Physiology |
| topics[0].display_name | Diet and metabolism studies |
| topics[1].id | https://openalex.org/T10401 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9979000091552734 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2712 |
| topics[1].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[1].display_name | Diabetes Treatment and Management |
| topics[2].id | https://openalex.org/T11171 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9970999956130981 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1311 |
| topics[2].subfield.display_name | Genetics |
| topics[2].display_name | Diabetes and associated disorders |
| is_xpac | False |
| apc_list.value | 300 |
| apc_list.currency | EUR |
| apc_list.value_usd | 323 |
| apc_paid.value | 300 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 323 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9172439575195312 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2781283889 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8509096503257751 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1130148 |
| concepts[1].display_name | Diabetic ketoacidosis |
| concepts[2].id | https://openalex.org/C2775849729 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6714783310890198 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1130148 |
| concepts[2].display_name | Ketoacidosis |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.632976770401001 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C134018914 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5862931609153748 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[4].display_name | Endocrinology |
| concepts[5].id | https://openalex.org/C2780606744 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5758289098739624 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q853930 |
| concepts[5].display_name | Starvation |
| concepts[6].id | https://openalex.org/C2778938600 |
| concepts[6].level | 3 |
| concepts[6].score | 0.575408399105072 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q389934 |
| concepts[6].display_name | Agonist |
| concepts[7].id | https://openalex.org/C2777391703 |
| concepts[7].level | 3 |
| concepts[7].score | 0.5242712497711182 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1053470 |
| concepts[7].display_name | Insulin resistance |
| concepts[8].id | https://openalex.org/C555293320 |
| concepts[8].level | 2 |
| concepts[8].score | 0.523349940776825 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12206 |
| concepts[8].display_name | Diabetes mellitus |
| concepts[9].id | https://openalex.org/C2776398474 |
| concepts[9].level | 4 |
| concepts[9].score | 0.497008353471756 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q424611 |
| concepts[9].display_name | Glucagon-like peptide-1 |
| concepts[10].id | https://openalex.org/C2779306644 |
| concepts[10].level | 2 |
| concepts[10].score | 0.4850165545940399 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q2002370 |
| concepts[10].display_name | Insulin |
| concepts[11].id | https://openalex.org/C544821477 |
| concepts[11].level | 3 |
| concepts[11].score | 0.4118177890777588 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q718113 |
| concepts[11].display_name | Weight loss |
| concepts[12].id | https://openalex.org/C511355011 |
| concepts[12].level | 2 |
| concepts[12].score | 0.3963389992713928 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q12174 |
| concepts[12].display_name | Obesity |
| concepts[13].id | https://openalex.org/C170493617 |
| concepts[13].level | 2 |
| concepts[13].score | 0.3772379457950592 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[13].display_name | Receptor |
| concepts[14].id | https://openalex.org/C2777180221 |
| concepts[14].level | 3 |
| concepts[14].score | 0.3257821500301361 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[14].display_name | Type 2 diabetes |
| concepts[15].id | https://openalex.org/C2781232474 |
| concepts[15].level | 3 |
| concepts[15].score | 0.19198453426361084 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q124407 |
| concepts[15].display_name | Type 1 diabetes |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9172439575195312 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/diabetic-ketoacidosis |
| keywords[1].score | 0.8509096503257751 |
| keywords[1].display_name | Diabetic ketoacidosis |
| keywords[2].id | https://openalex.org/keywords/ketoacidosis |
| keywords[2].score | 0.6714783310890198 |
| keywords[2].display_name | Ketoacidosis |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.632976770401001 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/endocrinology |
| keywords[4].score | 0.5862931609153748 |
| keywords[4].display_name | Endocrinology |
| keywords[5].id | https://openalex.org/keywords/starvation |
| keywords[5].score | 0.5758289098739624 |
| keywords[5].display_name | Starvation |
| keywords[6].id | https://openalex.org/keywords/agonist |
| keywords[6].score | 0.575408399105072 |
| keywords[6].display_name | Agonist |
| keywords[7].id | https://openalex.org/keywords/insulin-resistance |
| keywords[7].score | 0.5242712497711182 |
| keywords[7].display_name | Insulin resistance |
| keywords[8].id | https://openalex.org/keywords/diabetes-mellitus |
| keywords[8].score | 0.523349940776825 |
| keywords[8].display_name | Diabetes mellitus |
| keywords[9].id | https://openalex.org/keywords/glucagon-like-peptide-1 |
| keywords[9].score | 0.497008353471756 |
| keywords[9].display_name | Glucagon-like peptide-1 |
| keywords[10].id | https://openalex.org/keywords/insulin |
| keywords[10].score | 0.4850165545940399 |
| keywords[10].display_name | Insulin |
| keywords[11].id | https://openalex.org/keywords/weight-loss |
| keywords[11].score | 0.4118177890777588 |
| keywords[11].display_name | Weight loss |
| keywords[12].id | https://openalex.org/keywords/obesity |
| keywords[12].score | 0.3963389992713928 |
| keywords[12].display_name | Obesity |
| keywords[13].id | https://openalex.org/keywords/receptor |
| keywords[13].score | 0.3772379457950592 |
| keywords[13].display_name | Receptor |
| keywords[14].id | https://openalex.org/keywords/type-2-diabetes |
| keywords[14].score | 0.3257821500301361 |
| keywords[14].display_name | Type 2 diabetes |
| keywords[15].id | https://openalex.org/keywords/type-1-diabetes |
| keywords[15].score | 0.19198453426361084 |
| keywords[15].display_name | Type 1 diabetes |
| language | en |
| locations[0].id | doi:10.12890/2024_004357 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2737828108 |
| locations[0].source.issn | 2284-2594 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2284-2594 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | European Journal of Case Reports in Internal Medicine |
| locations[0].source.host_organization | https://openalex.org/P4310317697 |
| locations[0].source.host_organization_name | SMC MEDIA SRL |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310317697 |
| locations[0].source.host_organization_lineage_names | SMC MEDIA SRL |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://www.ejcrim.com/index.php/EJCRIM/article/download/4357/3891 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | European Journal of Case Reports in Internal Medicine |
| locations[0].landing_page_url | https://doi.org/10.12890/2024_004357 |
| locations[1].id | pmid:38584893 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | European journal of case reports in internal medicine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38584893 |
| locations[2].id | pmh:oai:doaj.org/article:876846ae5922444bacbffc2e7df2d450 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | European Journal of Case Reports in Internal Medicine (2024) |
| locations[2].landing_page_url | https://doaj.org/article/876846ae5922444bacbffc2e7df2d450 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:10997393 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Eur J Case Rep Intern Med |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10997393 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5111143850 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Pathan Mohamad Rafe Iqbal |
| authorships[0].affiliations[0].raw_affiliation_string | Internal Medicine Department, New Ahamdi Hospital, Kuwait Oil Company, Fahahil, Kuwait |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Pathan Mohamad Rafe Iqbal |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Internal Medicine Department, New Ahamdi Hospital, Kuwait Oil Company, Fahahil, Kuwait |
| authorships[1].author.id | https://openalex.org/A5078350713 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Ossama Maadarani |
| authorships[1].affiliations[0].raw_affiliation_string | Internal Medicine Department, Ahmadi Hospital, Kuwait Oil Company, Fahahil, Kuwait |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ossama Sajeh Maadarani |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Internal Medicine Department, Ahmadi Hospital, Kuwait Oil Company, Fahahil, Kuwait |
| authorships[2].author.id | https://openalex.org/A5016013008 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-8426-8685 |
| authorships[2].author.display_name | Zouheir Bitar |
| authorships[2].affiliations[0].raw_affiliation_string | Internal Medicine Department, Ahmadi Hospital, Kuwait Oil Company, Fahahil, Kuwait |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | Zouheir Ibrahim Bitar |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Internal Medicine Department, Ahmadi Hospital, Kuwait Oil Company, Fahahil, Kuwait |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ejcrim.com/index.php/EJCRIM/article/download/4357/3891 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Tirzepatide-induced ketoacidosis in non-diabetic patients |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12267 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2737 |
| primary_topic.subfield.display_name | Physiology |
| primary_topic.display_name | Diet and metabolism studies |
| related_works | https://openalex.org/W2003548227, https://openalex.org/W2977566213, https://openalex.org/W155406078, https://openalex.org/W2142759663, https://openalex.org/W2036520486, https://openalex.org/W94131833, https://openalex.org/W2345731205, https://openalex.org/W2017127800, https://openalex.org/W2611456965, https://openalex.org/W4224990278 |
| cited_by_count | 9 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 6 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 3 |
| locations_count | 4 |
| best_oa_location.id | doi:10.12890/2024_004357 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2737828108 |
| best_oa_location.source.issn | 2284-2594 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2284-2594 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | European Journal of Case Reports in Internal Medicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310317697 |
| best_oa_location.source.host_organization_name | SMC MEDIA SRL |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310317697 |
| best_oa_location.source.host_organization_lineage_names | SMC MEDIA SRL |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://www.ejcrim.com/index.php/EJCRIM/article/download/4357/3891 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | European Journal of Case Reports in Internal Medicine |
| best_oa_location.landing_page_url | https://doi.org/10.12890/2024_004357 |
| primary_location.id | doi:10.12890/2024_004357 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2737828108 |
| primary_location.source.issn | 2284-2594 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2284-2594 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | European Journal of Case Reports in Internal Medicine |
| primary_location.source.host_organization | https://openalex.org/P4310317697 |
| primary_location.source.host_organization_name | SMC MEDIA SRL |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310317697 |
| primary_location.source.host_organization_lineage_names | SMC MEDIA SRL |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://www.ejcrim.com/index.php/EJCRIM/article/download/4357/3891 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | European Journal of Case Reports in Internal Medicine |
| primary_location.landing_page_url | https://doi.org/10.12890/2024_004357 |
| publication_date | 2024-03-11 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2031939537, https://openalex.org/W3045729180, https://openalex.org/W4281934192, https://openalex.org/W2067978628, https://openalex.org/W2140336882, https://openalex.org/W3183842190, https://openalex.org/W3090176981, https://openalex.org/W4286310775, https://openalex.org/W3086646659, https://openalex.org/W1892323012, https://openalex.org/W3177122952, https://openalex.org/W3206074040, https://openalex.org/W2168854431, https://openalex.org/W1935184657, https://openalex.org/W3213712543, https://openalex.org/W3205201678, https://openalex.org/W4226331173 |
| referenced_works_count | 17 |
| abstract_inverted_index.a | 3 |
| abstract_inverted_index.It | 13 |
| abstract_inverted_index.We | 28 |
| abstract_inverted_index.an | 41 |
| abstract_inverted_index.in | 23, 40, 67 |
| abstract_inverted_index.is | 2 |
| abstract_inverted_index.of | 33, 38, 49 |
| abstract_inverted_index.to | 46 |
| abstract_inverted_index.GIP | 60 |
| abstract_inverted_index.The | 56 |
| abstract_inverted_index.and | 20, 52, 59 |
| abstract_inverted_index.can | 64 |
| abstract_inverted_index.for | 17 |
| abstract_inverted_index.the | 30, 36, 47 |
| abstract_inverted_index.use | 37 |
| abstract_inverted_index.was | 14 |
| abstract_inverted_index.Case | 26 |
| abstract_inverted_index.case | 32 |
| abstract_inverted_index.GLP-1 | 58 |
| abstract_inverted_index.after | 35 |
| abstract_inverted_index.first | 31 |
| abstract_inverted_index.novel | 4 |
| abstract_inverted_index.obese | 42, 68 |
| abstract_inverted_index.induce | 65 |
| abstract_inverted_index.report | 29 |
| abstract_inverted_index.weight | 21 |
| abstract_inverted_index.control | 19 |
| abstract_inverted_index.insulin | 53 |
| abstract_inverted_index.peptide | 6, 9 |
| abstract_inverted_index.agonist. | 12 |
| abstract_inverted_index.approved | 16 |
| abstract_inverted_index.diabetes | 18 |
| abstract_inverted_index.patient, | 44 |
| abstract_inverted_index.recently | 15 |
| abstract_inverted_index.receptor | 11, 61 |
| abstract_inverted_index.agonists, | 62 |
| abstract_inverted_index.patients. | 25, 70 |
| abstract_inverted_index.reduction | 22 |
| abstract_inverted_index.secondary | 45 |
| abstract_inverted_index.starvation | 50 |
| abstract_inverted_index.(GLP-1/GIP) | 10 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.Conclusion: | 55 |
| abstract_inverted_index.Tirzepatide | 1 |
| abstract_inverted_index.dual-acting | 57 |
| abstract_inverted_index.possibility | 48 |
| abstract_inverted_index.resistance. | 54 |
| abstract_inverted_index.tirzepatide | 39 |
| abstract_inverted_index.description: | 27 |
| abstract_inverted_index.ketoacidosis | 34, 51, 66 |
| abstract_inverted_index.non-diabetic | 24, 43, 69 |
| abstract_inverted_index.tirzepatide, | 63 |
| abstract_inverted_index.glucagon-like | 5 |
| abstract_inverted_index.insulinotropic | 8 |
| abstract_inverted_index.1/glucose-dependent | 7 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 96 |
| countries_distinct_count | 0 |
| institutions_distinct_count | 3 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8299999833106995 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.93943221 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |